Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) COGS-to-Revenue : 0.52 (As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co COGS-to-Revenue?

Skystar Bio-Pharmaceutical Co's Cost of Goods Sold for the three months ended in Sep. 2014 was $9.59 Mil. Its Revenue for the three months ended in Sep. 2014 was $18.35 Mil.

Skystar Bio-Pharmaceutical Co's COGS to Revenue for the three months ended in Sep. 2014 was 0.52.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Skystar Bio-Pharmaceutical Co's Gross Margin % for the three months ended in Sep. 2014 was 47.75%.

Skystar Bio-Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co COGS-to-Revenue Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

COGS-to-Revenue

Get a 7-Day Free Trial

0.49

0.46

0.50

0.45

0.49

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
COGS-to-Revenue	Get a 7-Day Free Trial															0.49	0.51	0.59	0.55	0.52

Skystar Bio-Pharmaceutical Co COGS-to-Revenue Calculation

Skystar Bio-Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2013 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	20.993	/	42.484
	=	0.49

Skystar Bio-Pharmaceutical Co's COGS to Revenue for the quarter that ended in Sep. 2014 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	9.59	/	18.353
	=	0.52

Skystar Bio-Pharmaceutical Co (GREY:SKBI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Skystar Bio-Pharmaceutical Co's Gross Margin % for the three months ended in Sep. 2014 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	9.59 / 18.353
	=	47.75 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Skystar Bio-Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (GREY:SKBI) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Headlines

No Headlines